Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk.

A study published by researchers from the Sant Pau Research Institute (IR Sant Pau) and the Stroke Unit of Sant Pau Hospital ...

High levels of cholesterol puts heart at severe risk. Here are few signs and symptoms that may appear at night when the LDL ...

Tracking lipid variability may be a reliable method of predicting dementia and cognitive decline among community-dwelling ...

Lipoprotein apheresis involves the extracorporeal removal of LDL and lipoprotein(a) particles from whole blood or plasma by adsorption, precipitation or differential filtration. Used repetitively ...

Learn about common foods that can raise cholesterol levels and how they affect your heart health. Get insights on smarter ...

In a recent paper by Nikanjam and colleagues, synthetic low-density lipoprotein-like nanoparticles were prepared from commercial lipids and a bifunctional synthetic peptide containing the low ...

The test, which is intended for assessing cardiovascular risk, is the first lipoprotein (a), or Lp(a) test measured in nanomoles per liter to receive FDA clearance.

A study recently published by researchers from the Sant Pau Research Institute (IR Sant Pau) and the Stroke Unit of Sant Pau Hospital in the Journal ...

Atherosclerosis is the primary cause of cardiovascular disease, and the risk for atherosclerosis is inversely proportional to circulating levels of high-density lipoprotein (HDL) cholesterol.

The Lipoprotein LAB (LLAB) is a dedicated research group committed to advancing the field of pharmaceutics through the application of mechanistic principles governing the functions of lipoproteins and ...